TickerFacts.

Galmed Pharmaceuticals Ltd. (EOCN): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Operating Income or Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$30.17M
Year ended 2020-12-31
2017-12-31: -$12.12M2018-12-31: -$10.33M2019-12-31: -$22.34M2020-12-31: -$30.17M-$30.17M
2017-12-31 EBITDA (USD) 2020-12-31
Period endedEBITDAChange YoYSource filing
2020-12-31-$30.17Mn/m2023-03-29, From 2020-01-01
2019-12-31-$22.34Mn/m2022-05-02, From 2019-01-01
2018-12-31-$10.33Mn/m2021-03-18, From 2018-01-01
2017-12-31-$12.12Mn/a2020-03-12, From 2017-01-01